B ecause most patients with trochanteric fractures are older adults, operative treatment must be rapid and permit immediate postoperative weight bearing. 1 Intramedullary fixation devices have become increasingly popular due to biomechanical advantages in the treatment of unstable trochanteric fractures compared with extramedullary fixation. 2, 3 However, previous intramedullary fixation devices, such as the Gamma nail 4 (Howmedica, London, United Kingdom) and Proximal Femoral Nail, 5, 6 (Synthes, Solothurn, Switzerland) resulted in persistent problems-including femoral shaft fracture, 7 fixation failure, 8 the Z effect, 9 and distal locking complications 10 -requiring reoperation with subsequent morbidity and even mortality. Therefore, other intramedullary fixation devices have been introduced. The Proximal Femoral Nail Antirotation (PFNA), 11 a modification of the Proximal Femoral Nail, uses helical neck blade fixation to obtain high stability to prevent rotation and collapse. The helical blade avoids bone loss that occurs during the drilling and insertion of the standard sliding hip screw. This device allows for improved purchase in the femoral head by radial compaction of the cancellous bone around the blade during insertion. The helical neck blade has the advantages of fixation stability, antirotation, and antivarus collapse. 12 However, because its proximal diameter of 17 mm is too large for the Asian proximal femur, intra-and postoperative complications, such as difficulty inserting it, pain in the hip and thigh, femoral shaft fracture, lateral blade migration, and lateral cortex splitting intraoperatively, have been reported since it began being used in Asian patients. 13, 14 In response to these concerns, AO/ASIF developed the Proximal Femoral Nail Antirotation-Asia (PFNA-II) specifically for Asian patients. Previous studies have demonstrated that the flat lateral shape of the PFNA-II is better suited for the femurs of Asian patients by reducing the chances of impingement with the lateral proximal femoral cortex during intraoperative reduction of subtrochanteric fractures. 15 Similarly, a new device, the InterTan nail (Smith & Nephew, Memphis, Tennessee), uses 2 cephalocervical screws in an integrated mechanism allowing linear intraoperative compression and rotational stability of the head-neck fragments. 16 A biomechanical study showed that the InterTan nail possesses some biomechanical benefits for internal fixation of unstable femoral neck fractures compared with dynamic hip screw and cannulated screw. 17 Meanwhile, clinical outcomes show that the InterTan nail appears to be a reliable implant for the treatment of intertrochanteric femoral fractures. 18 Its design provides for stability against rotation and minimizes neck malunions (shortening) through linear intraoperative compression of the head-neck segment to the shaft. 16 Although both nails have been reported to have good clinical outcomes, no randomized, controlled trial has compared the outcomes of the PFNA-II and InterTan nail. Therefore, the goal of the current prospective, randomized clinical trial was to compare the PFNA-II and InterTan nail in terms of intraoperative use and outcomes.
Materials and Methods
Between July 2009 and September 2010, a total of 132 consecutive patients with unstable trochanteric fractures of the femur (AO/ASIF classifications, 31-A2.1-3 and 31-A3.1-3) were included in this study. The study was approved by the ethics committees of the authors' institutions. Informed consent was obtained from the patients or from family members if the patients were unable to consent. Patients with unstable trochanteric fracture caused by a low-energy trauma were considered eligible for the study. Exclusion criteria included highenergy trauma, pathologic fractures, open fractures, multiple fractures, American Society of Anesthesiologists (ASA) score of V, inability to work before injury, and presence of degenerative osteoarthritis/ arthritis in the injured hip.
A total of 113 patients met the inclusion criteria. They were randomized to a PFNA-II group (n556) and an InterTan group (n557), which was accomplished with the use of consecutive numbered and sealed envelopes based on a computergenerated list. Sealed envelopes were opened by the surgeon (K.Z., Y.J.) preoperatively. General data were collected from the patients regarding age, sex, fracture type according to OTA classification, and ASA score with regard to preoperative comorbidities (Table 1 ). Both treatment groups were comparable in terms of general data preoperatively.
The surgical procedures were comparable between the 2 groups, other than the type of nail used. All surgeries were performed by surgeons (B.Y., W.F.) who had performed at least 5 procedures independently with either the PFNA-II or InterTan nail. General anesthesia and spinal anesthesia were used in both groups. Patients underwent prophylaxis for thrombosis perioperatively and received prophylactic antibiotics 30 minutes preoperatively. Patients were operated on while in a supine position a traction table, and, if possible, closed reduction was performed with the help of the C arm.
Surgery was performed according to the standard protocols for the PFNA-II and InterTan nails, which are recommended by the manufacturer and have been described in earlier studies. 15, 16 The PFNA-II nail used in the current study is a solid titanium nail that is 2003170 mm long and 9, 10, or 11 mm in diameter. The InterTan nail has a trapezoidal proximal end 180 mm long and a diameter decreasing from 15.25316.25 mm at the proximal end to 11 mm at the distal end. The proximal end of the nail will accept 2 cephalocervical screws: a larger superior 11-mm lag screw and a smaller 7-mm compression screw. The smaller screw is integrated into the larger and has the effect of creating an oval screw with a composite diameter of 15.5 mm.
Both nails were inserted using a percutaneous technique.
Postoperatively, analgesic care and diet were related to local standards and equal for both groups. The 2 groups were compared regarding intraoperative time, fluoroscopy time, intraoperative blood loss, length of hospital stay, and complications. Postoperatively, all patients had suction drains placed for 48 hours and were given prophylactic antibiotics for 24 hours. Continuous passive motion was used twice daily after the drainage tubes were removed. Plain anteroposterior and lateral radiographs were obtained on postoperative day 1 and analyzed for fracture reduction and implant position. All patients were encouraged to walk with full weight bearing, while assisted by a physiotherapist, as soon as possible postoperatively.
Follow-up occurred at 1, 3, 6, and 12 months postoperatively and yearly thereafter. Plain anteroposterior and lateral radiographs were obtained at each visit (Figures 1, 2 ). All implant position changes, complications, and fixation failures were recorded. At each follow-up, hip range of motion; pain in the hip and thigh; walking ability score; postoperative complications, including wound infection and pulmonary, cardiovascular, thromboem- On postoperative radiographs, fracture reduction was considered anatomical in 85 patients (44 in the PFNA-II group and 41 in the InterTan group), and implant position was considered optimal in 92 patients (47 in the PFNA-II group and 45 in the InterTan group). No significant differences existed in the quality of reduction between the implants and fracture types (31-A2 and -A3). The tipapex distances were comparable between the 2 groups. Mean hospital stay did not differ significantly between the 2 groups (P5.391).
Nineteen local intraoperative complications occurred, 9 in the PFNA-II group and 10 in the InterTan group (P5.973). Iatrogenic femoral shaft fractures were noted in 3 patients (2 in the PFNA-II group and 1 in the InterTan group; P5.735), all of whom were short, older adult Chinese women treated with a 200-mm PFNA-II or InterTan nail. The new injury was treated successfully with a long PFNA-II or InterTan nail instead. Seven lateral greater trochanter fractures caused by insertion of the nail were observed intraoperatively (1 in the PFNA-II group and 6 in the InterTan group; P5.008). They were minor splits in the lateral cortex of the proximal femur in more unstable fracture patterns (31-A2.3 and 31-A3.3) with just acceptable reduction and were successfully treated with conservative management and delayed full weight bearing. Distal interlocking difficulty was observed in 2 patients (1 in each group). The proximal end of the nail penetrated the top of the trochanter in 4 patients in the PFNA-II group and 1 in the InterTan group (P5.018) ( Table 3) .
Of the 113 patients treated during the study period, 20% were not available for follow-up. Five (4.4%) were lost to followup at 12 months (3 in the PFNA-II group and 2 in the InterTan group) because they were too ill, and another 15 (13.3%) died within 12 months postoperatively ( in the PFNA-II group and 1464.86 weeks (range, 10-21 weeks) in the InterTan group. Six main postoperative complications occurred in the study, including femoral shaft fracture, cutout, lateral blade migration, hematoma, deep infection, and superficial wound infection. Two cutouts occurred through the femoral head and neck in the PFNA-II group (including 1 helical blade penetrating into the pelvis), but none occurred in the InterTan group. One patient in the PFNA-II group sustained a fall 2 months postoperatively, resulting in a femoral shaft fracture, which was treated with plating. Four patients experienced lateral blade migration in the PFNA-II group, but none did in the InterTan group. No significant differences existed between the 2 groups regarding other complications (Table 4) .
General complications were comparable between the 2 groups. Mean femoral neck shortening caused by fracture compression was 1.1 mm (range, 0-13 mm) in the PFNA-II group and 3.2 mm (range, 1-24 mm) in the InterTan group, which was a significant difference (P5.021). No significant between-group differences existed with regard to walking ability and hip range of motion at final followup. Harris Hip Scores showed no differences in function between the 2 groups at final follow-ups (Table 5 ). Several patients reported hip and thigh pain during the follow-up period: 14 (30.4%) patients in the PFNA-II group and 5 (10.6%) in the InterTan group) (P5.001). The incidence of muscle weakness was higher in the InterTan group (n58; 17.0%) than in the PFNA-II group (n54; 8.7%), but it was not significantly different (P5.092). Other symptoms were comparable between the groups.
discussion
The current study had a mean operative time of 66.5615.2 minutes in the InterTan group, longer than that reported by Ruecker et al 16 at 41615 minutes. This may be associated with fracture type. All of the fractures in the current study were unstable and therefore more difficult to reduce. It may also be related to the design of the nail. The InterTan nail has a trapezoidal proximal end that is not easy to insert into a poorly reduced marrow cavity, and insertion of the interlocking nail may lead to a loss of reduction. Repeated reduction and manipulation will increase operative and fluoroscopy time and intraoperative blood loss, especially in more unstable fracture types (AO/ASIF 31-A2.3 and 31-A3.3). This problem is frequently seen in short, older adult Chinese women, especially those with osteoporosis. When reaming is not enough for inserting the nail, the lateral cortex of the proximal femur may split as the nail is hammered into the marrow cavity. In the current study, this complication occurred in 6 patients, all older adult women. In addition, perfect implant position cannot always be achieved because it is difficult to insert the nail completely into the cavity even when the lateral wall becomes thin after repeated reaming. The authors suggest that the PFNA-II nail should be the first choice in the treatment of older adult women with osteoporosis or patients with more unstable fracture patterns, and, if possible, open reduction should be performed. The decrease in the diameter of the InterTan nail may also be helpful, but more anatomic measurements are needed.
Hip and thigh pain is a common complication in previous reports and occurred in up to 90.1% of patients during follow-up. 14, 19 One explanation may be the inevitable damage to the gluteus medius tendon during appropriate placement of the intramedullary nail, as reported in previous studies. 20 Another explanation may be the chronic muscle injury caused by the over-long proximal end of the nail protruding into the great trochanter, but this has been significantly improved in with PFNA-II compared with the PFNA. The rate of hip and thigh pain in this study was significantly lower than that in previous reports, 14, 19 and higher in the PFNA-II group than in the InterTan group. Similar results were reported by Lv et al 15 and Ruecker et al, 16 who reported no hip and thigh pain with the use of the PFNA-II or InterTan nail. This may be related to the overall instability of the bone-implantconstructed uneven stress distribution between the implants and inner bone cortex.
The PFNA-II nail, the diameter of which is uniform from the bending point to the distal tip, cannot always obtain good contact with the bone from the lesser trochanter to the isthmus. Moreover, the 200-mm-long distal tip of the intramedullary PFNA-II nail is biased to the anterior side of the inner cortex so that stress concentration can more easily occur around, making the femoral shaft more vulnerable to fracture compared with the InterTan nail or leading to long-term middle thigh pain. In contrast, the diameter of the InterTan nail tapers from 13.5 mm in the middle to 11 mm at the tip, which is in line with the variation of the proximal femoral modularly cavity and more closely integrated with the inner cortex. Such a design has a stress dispersion effect on the InterTan nail and inner cortex and avoids stress overconcentration around the nail tip. In addition, the "clothes-pin" distal tip of the 22-mm nail contributes to alleviating this problem, reducing the overall cross-sectional stiffness of the implant distally. 16 Varus collapse of the head and neck caused by lag screw cutout or lateral protrusion is one of the most common postoperative complications that lead to surgical failure in intertrochanteric fractures. Cutout rates, including the Z effect, have been reported to range from 3% to 10% 7, 9, [21] [22] [23] [24] with the Gamma nail, Proximal Femoral Nail, and dynamic hip screw but are lower with the PFNA (1%-3%) 14 and with the InterTan (0%) nail. 16 Because the screw is rotationally unstable within the bone when using a single lag screw, flexion-extension of the limb results in loosening of the bone-screw interface, with the screw secondarily cutting out. Biomechanical studies and clinical reports have demonstrated that the InterTan and PFNA nails have good antirotation performance. 14, 17, 19 Although other devices, such as the Proximal Femoral Nail, feature 2 separate screws placed into the head and neck fragments in a reconstruction mode and tend to resist rotation of the head and neck segment during hip motion, these devices are associated with the Z effect, 9, 25 where the superior screw bears a disproportionate amount of load during weight bearing. 26 Neck shortening is concerning to surgeons. [27] [28] [29] Although controlled fracture collapse on weight bearing is the key principle in dynamic devices featuring a sliding screw, uncontrolled collapse can result in unacceptable shortening of the head and neck segment (neck malunion), resulting in excessive shortening of the neck and, secondarily, the limb. A previous study suggested that excessive shortening of the neck (more than 5 mm) may cause weakness in the gluteus medius and thus limit hip joint movement. 28 The InterTan nail uses a hybrid worm-gear mechanism to convert rotational forces into linear compression. This characteristic can avoid shortening during healing. Most patients treated with the InterTan nail in the current study experienced approximately 3 mm of shortening of the neck segment, but fewer cases of shortening were observed in the PFNA-II group. By contrast, healing time was significantly shorter in the InterTan group than in the PFNA-II group. However, no significant differences existed in final functional outcomes between the 2 groups. The InterTan nail can reduce healing time and is a good choice for elderly patients who need to walk bearing full weight in the early postoperative period.
conclusion
This study compared the clinical outcomes of the PFNA-II and InterTan nails. The results suggest that mean operative and fluoroscopy time and intraoperative blood loss were greater in the InterTan group than in the PFNA-II group. Although intraoperative complications were comparable between the groups, the InterTan nail was more likely to cause a proximal lateral femoral fracture during insertion, whereas the PFNA-II nail was more likely to penetrate the proximal end of the femur. Harris Hip Scores and cutout rates were comparable between the groups, but the rate of thigh pain was lower in the InterTan group. The InterTan nail may result in more benefits for patients with unstable trochanteric fractures but needs some improvement to reduce the intraoperative complications.
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